ClinicalTrials.Veeva

Menu

Effects OF NMES With and Without Dynamic Bracing on Spasticity and Movement Quality in CP

R

Riphah International University

Status

Completed

Conditions

Diplegic Spastic Cerebral Palsy

Treatments

Other: Dynamic Bracing Only
Other: NMES without Dynamic Bracing
Other: NMES with Dynamic Bracing

Study type

Interventional

Funder types

Other

Identifiers

NCT06303336
REC/0258 Ayesha Ashraf

Details and patient eligibility

About

The study aims at comparing Neuromuscular electrical Stimulation with and without dynamic bracing on spasticity and movement quality of lower limb in Children with Cerebral Palsy

Full description

Cerebral palsy (CP) is a lifelong motor impairment caused by an early brain injury and affects 2-3 per 1,000 live births. It is a complex medical condition that negatively impacts cognition, language, sensations, movement, and gait patterns. It is normally carried out using a comprehensive approach that incorporates numerous approaches targeted at minimizing symptoms and improving functional outcomes.

NMES (Neuromuscular and Muscular Electrical Stimulation) is an instrument that provides electrical impulses to nerves, causing muscles to contract, while dynamic bracing use muscle power to pre-compress soft tissue to produce the high forces required to control specific pathological diseases.

The hip adductors, the knee flexor muscles, and the ankle and foot muscles (gastrocnemius and soleus may experience increased tone, causing the ankles to be held in a plantar-flexed (pointed downward) position) are targeted with NMES in the lower extremity to reduce the spasticity & improve the quality of movement in CP children. Investigating how combining NMES with dynamic bracing benefits lumbar disc bulge patients adds to the growing body of evidence supporting multimodal treatment.

Enrollment

42 patients

Sex

All

Ages

5 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 5 to 12 years.
  • Able to walk with or without an assistive device. Classification as level I-II on the Gross Motor Functional Classification System (GMFCS).
  • Able to stand with or without support for 1 minute.
  • Classification as levels I-III on the Manual Ability Classification System (MACS); and the ability to follow and accept verbal instructions.
  • Muscle tone scored ≥2, according to Modified Ashworth Scale.

Exclusion criteria

  • Orthopedic Surgical intervention (e.g. tendon lengthening in lower limb) within the previous 12 months
  • Treatment with botulinum toxin in the calf muscles within the previous 6 months
  • Presence of structural deformities at the lower limbs and trunk, or instability in the ankle joint, which could compromise the child's safety and performance of the motor task
  • Severe affective or psychiatric impairments;
  • Serious vision or hearing problems
  • Any neurological impairment (epilepsy or any other disease that would interfere with physical activity)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

42 participants in 3 patient groups

NMES with Dynamic Bracing
Experimental group
Description:
The NMES targeting the hip adductors, the knee flexor muscles and the ankle \& foot muscles, along with dynamic bracing
Treatment:
Other: NMES with Dynamic Bracing
NMES without Dynamic Bracing
Experimental group
Description:
Neuromuscular Electrical Stimulator targeting the lower extremity
Treatment:
Other: NMES without Dynamic Bracing
Dynamic Bracing Only
Experimental group
Description:
Dynamic Bracing of lower extremity
Treatment:
Other: Dynamic Bracing Only

Trial contacts and locations

1

Loading...

Central trial contact

Ammara abbas, tDPT; Aruba Saeed, PHD*

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems